Literature DB >> 1319627

Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.

J E Merrill1, M C Graves, D G Mulder.   

Abstract

Autoimmunity in the central and peripheral nervous system can manifest as the result of cellular or humoral immune responses to autoantigens. There is evidence that multiple sclerosis is a cell-mediated autoimmune disease of the central nervous system in which both myelin and the cell that produces the myelin are destroyed. Diseases such as acute inflammatory demyelinating polyneuropathy (also called Guillain-Barré syndrome) and myasthenia gravis are considered antibody-mediated diseases of the peripheral nervous system and neuromuscular junctions, respectively. We review these diseases and explore mechanisms of immune-mediated destruction of these nervous system components. We specifically focus on one effective therapy aimed at countering the immune attack, that of thymectomy in patients with myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319627      PMCID: PMC1003353     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  114 in total

1.  Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders.

Authors:  A Pestronk; R N Adams; R W Kuncl; D B Drachman; L L Clawson; D R Cornblath
Journal:  Neurology       Date:  1989-05       Impact factor: 9.910

2.  Systemic alpha-interferon therapy of multiple sclerosis.

Authors:  R L Knobler; H S Panitch; S L Braheny; J C Sipe; G P Rice; J R Huddlestone; G S Francis; C K Hooper; R M Kamin-Lewis; K P Johnson
Journal:  Neurology       Date:  1984-10       Impact factor: 9.910

Review 3.  Multiple sclerosis (first of two parts).

Authors:  D E McFarlin; H F McFarland
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

4.  Thymectomy for myasthenia gravis.

Authors:  D G Mulder; C Herrmann; J Keesey; H Edwards
Journal:  Am J Surg       Date:  1983-07       Impact factor: 2.565

5.  Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin.

Authors:  G H Wong; I Clark-Lewis; A W Harris; J W Schrader
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

6.  Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.

Authors:  J Keesey; F Naiem; J Lindstrom; D Roe; C Herrmann; R Walford
Journal:  Arch Neurol       Date:  1982-02

7.  Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

Authors:  A Fontana; F Kristensen; R Dubs; D Gemsa; E Weber
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Multiple sclerosis patients show an increased spontaneous activity of their peripheral blood monocytes as measured by chemiluminescence.

Authors:  K P Hammann; W Nix; M P Dierich; H C Hopf
Journal:  Acta Neurol Scand       Date:  1983-09       Impact factor: 3.209

9.  Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown.

Authors:  J W Prineas; J S Graham
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

10.  Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D A Hafler; A D Duby; S J Lee; D Benjamin; J G Seidman; H L Weiner
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  2 in total

1.  A Liposome-Based Approach to the Integrated Multi-Component Antigen Microarrays.

Authors:  Denong Wang
Journal:  Microarrays (Basel)       Date:  2015-11-20

2.  The TNFα-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss.

Authors:  L Creed Pettigrew; Richard J Kryscio; Christopher M Norris
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.